Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer

被引：0
|
作者：
Masayuki Aboshi
Masayuki Kaneko
Mamoru Narukawa
机构：
[1] Kitasato University Graduate School of Pharmaceutical Sciences,Department of Clinical Medicine (Pharmaceutical Medicine)
来源：
Journal of Cancer Research and Clinical Oncology | 2014年 / 140卷
关键词：
Meta-analysis; Overall survival; Progression-free survival; Post-progression survival; Non-small cell lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：839 / 848
页数：9
相关论文
共 50 条
  • [1] Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer
    Aboshi, Masayuki
    Kaneko, Masayuki
    Narukawa, Mamoru
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (05) : 839 - 848
  • [2] Relationship between progression-free survival and overall survival in patients with advanced non-small cell lung cancer treated with anticancer agents after first-line treatment failure
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Okamoto, Norio
    Yamadori, Tadahiro
    Tamiya, Motohiro
    Morishita, Naoko
    Shiroyama, Takayuki
    Takeoka, Sawa
    Osa, Akio
    Azuma, Yuichiro
    Kawase, Ichiro
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 (02) : 121 - 128
  • [3] BASELINE POPULATION CHARACTERISTICS AND THE ASSOCIATION BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN ADVANCED NON SMALL CELL LUNG CANCER PATIENTS
    Kulakova, M.
    Hashim, M.
    Pfeiffer, B.
    Postma, M.
    Heeg, B.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A420 - A421
  • [4] Time trends in overall survival (OS) and progression-free survival (PFS) in the first-line treatment of advanced non-small-cell lung cancer (NSCLC).
    Rutkowski, Jacek
    Saad, Everardo D.
    Buyse, Marc E.
    Jassem, Jacek
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non-Small Cell Lung Cancer
    Popat, Sanjay
    Liu, Stephen V.
    Scheuer, Nicolas
    Gupta, Alind
    Hsu, Grace G.
    Ramagopalan, Sreeram V.
    Griesinger, Frank
    Subbiah, Vivek
    [J]. JAMA NETWORK OPEN, 2022, 5 (05) : E2214046
  • [6] Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy
    Singh, Apurva
    Horng, Hannah
    Roshkovan, Leonid
    Weeks, Joanna K.
    Hershman, Michelle
    Noel, Peter
    Luna, Jose Marcio
    Cohen, Eric A.
    Pantalone, Lauren
    Shinohara, Russell T.
    Bauml, Joshua M.
    Thompson, Jeffrey C.
    Aggarwal, Charu
    Carpenter, Erica L.
    Katz, Sharyn, I
    Kontos, Despina
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01):
  • [7] Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy
    Apurva Singh
    Hannah Horng
    Leonid Roshkovan
    Joanna K. Weeks
    Michelle Hershman
    Peter Noël
    José Marcio Luna
    Eric A. Cohen
    Lauren Pantalone
    Russell T. Shinohara
    Joshua M. Bauml
    Jeffrey C. Thompson
    Charu Aggarwal
    Erica L. Carpenter
    Sharyn I. Katz
    Despina Kontos
    [J]. Scientific Reports, 12 (1)
  • [8] Impact of Advantage in Tumor Response on the Correlation Between Progression-Free Survival and Overall Survival: Meta-Analysis of Clinical Trials in Patients with Advanced Non-Small Cell Lung Cancer
    Yoshida, Yosuke
    Kaneko, Masayuki
    Narukawa, Mamoru
    [J]. PHARMACEUTICAL MEDICINE, 2021, 35 (02) : 81 - 92
  • [9] Association Between Intermediate End Points, Progression-free Survival, and Overall Survival in First-line Advanced or Recurrent Endometrial Cancer
    Garside, Jamie
    Shen, Qin
    Westermayer, Bernd
    van de Ven, Michiel
    Kroep, Sonja
    Chirikov, Viktor
    Juhasz-Boess, Ingolf
    [J]. CLINICAL THERAPEUTICS, 2023, 45 (10) : 983 - 990
  • [10] Impact of Advantage in Tumor Response on the Correlation Between Progression-Free Survival and Overall Survival: Meta-Analysis of Clinical Trials in Patients with Advanced Non-Small Cell Lung Cancer
    Yosuke Yoshida
    Masayuki Kaneko
    Mamoru Narukawa
    [J]. Pharmaceutical Medicine, 2021, 35 : 81 - 92
12345